Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria CRESY NASDAQ · Industrials · Argentina
$7.79 -2.81% -$0.23
Summary
53 / 100 · Bulios Score
What speaks for it
- Revenue grew by 25% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Repaying its net debt would take 4.9 years of operating profit.
- It pays out more in dividends than it earns: 115% of profit.
- It reports a profit, yet spends more cash than it brings in.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.7 ARS for 1 ARS of yearly profit. Over the last five years it was 5.3 ARS on average.
Valuation in detailIs it growing?
SlowlyRevenue (ARS)
Diluted EPS (ARS)
- Analyst estimate
Revenue grew by 56% a year over 5 years. Over the last 3 years it grew by 25% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 ARS of revenue goes
- Cost of sales 59 ARS
- Research and development 0.5 ARS
- Sales and administration 11 ARS
- Taxes and other 19 ARS
- Net profit 9.6 ARS
Net profit, industry median (Conglomerates) 6.2 ARS
Out of every 100 ARS of revenue, 9.6 ARS is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 17.21%
- Paid out of profit
- 115%
You receive $0.75 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $12.68 is 63% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- Other Countries 50%
- Brazil 50%
Other Countries brings in 50% of revenue.
Segments in detail